ClinicalTrials.gg
RecruitingNCT06491212Updated Jul 9, 2024

The Relationship Between Pes Planus, Diaphragm, Postural Control, and Plantar Pressure

An interventional study of Determination of Foot Deformity Level and Foot Function Index in Pes Planus, Diaphragm Issues and Plantar Pressure, sponsored by Alanya Alaaddin Keykubat University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-09.

Sponsored by Alanya Alaaddin Keykubat University · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started May 2024; still recruiting 2 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Non-randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

Our primary aim is to compare diaphragm function (resting thickness, activity/resting thickness ratio indicating contractility), postural control, and plantar pressure between individuals with pes planus and healthy controls without pes planus.

Read the detailed description

Pes planus deformity, by causing pronation during standing, affects the biomechanics of the lower extremities. Improper foot positioning can lead to changes in load distribution under the sole, and consequently, abnormal tensions in the soft tissues of the feet can spread to the upper body parts through the myofascial system. In light of all this information, our primary aim is to examine the diaphragm function and thickness in individuals with pes planus deformity and healthy individuals, and to investigate the relationship between diaphragm thickness and balance. Additionally, our secondary aim is to evaluate the relationship between pes planus, diaphragm thickness, and balance.

02

Conditions studied

  • Pes Planus
  • Diaphragm Issues
  • Plantar Pressure
  • Postural Control

Browse trials for

03

In context

Flatfoot

173 studies on the registry are indexed under Flatfoot; 44 are open to participants now.

This study's planned enrollment of 34 is below the median of 40 across 122 interventional studies indexed under Flatfoot.

Browse Flatfoot studies →

Lead sponsor

Alanya Alaaddin Keykubat University is the lead sponsor of 51 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

Inclusion criteria for individuals with Pes Planus Deformity

  • Willing to participate in the study voluntarily
  • Having a Navicular drop test value of 10mm or above
  • Being between the ages of 18-30
  • Having the physical capacity to perform assessments and tests
  • Having a of 18-25 kg/m²

Exclusion Criteria:

  • Exclusion criteria for individuals with Pes Planus Deformity:
  • Termination of voluntariness
  • Those with rigid flatfoot, pes cavus, hallux valgus, hallux rigidus, or calcaneal spur deformity
  • Those with chronic systematic and metabolic diseases (e.g., diabetes mellitus, rheumatoid arthritis, etc.) and musculoskeletal problems (e.g., pes planus) that may affect foot functions and gait
  • Those with any surgical history likely to affect balance, lower extremity strength, and postural control
  • Those with any visual/vestibular, musculoskeletal, or neurological problems"

Inclusion criteria for healthy participants:

  • Willing to participate in the study voluntarily
  • Being between the ages of 18-30
  • Having the physical capacity to perform assessments and tests
  • Having a body mass index of 18-25 kg/m²
  • Having the ideal height of the medial longitudinal arch of the foot (not having pes planus)

Exclusion criteria for healthy participants:

  • Termination of voluntariness
  • Those with chronic systematic and metabolic diseases (e.g., diabetes mellitus, rheumatoid arthritis, etc.) and musculoskeletal problems (e.g., pes planus) that may affect foot functions and gait
  • Those with any surgical history likely to affect balance, lower extremity strength, and postural control
  • Those with any visual/vestibular, musculoskeletal, or neurological problems"
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
34 participants (estimated)

Study arms

  • Experimental
    People with pes planus

    Individuals with pes planus that we identified according to the inclusion criteria will be evaluated in this group.

    Diagnostic Test: Determination of Foot Deformity Level · Diagnostic Test: Foot Function Index · Diagnostic Test: UFAA-International Physical Activity Questionnaire · Diagnostic Test: Diaphragm ultrasound measurements · Diagnostic Test: NeuruCom Balance Master Balnce and Performans Test · Diagnostic Test: Plantar Pressure Assessment

  • Active comparator
    Healthy People

    Volunteer individuals without pes planus who meet the inclusion criteria will be evaluated for comparison in this group

    Diagnostic Test: Determination of Foot Deformity Level · Diagnostic Test: Foot Function Index · Diagnostic Test: UFAA-International Physical Activity Questionnaire · Diagnostic Test: Diaphragm ultrasound measurements · Diagnostic Test: NeuruCom Balance Master Balnce and Performans Test · Diagnostic Test: Plantar Pressure Assessment

Interventions

  • Diagnostic testDetermination of Foot Deformity Level

    One of the methods used in our study to determine the presence and degree of pes planus is the navicular drop test.

  • Diagnostic testFoot Function Index

    Evaluation of Foot Function

  • Diagnostic testUFAA-International Physical Activity Questionnaire

    To determination of physical activity level.

  • Diagnostic testDiaphragm ultrasound measurements

    Rehabilitative ultrasound imaging is a method frequently used by physiotherapists to assess muscle function.

  • Diagnostic testNeuruCom Balance Master Balnce and Performans Test

    Balance master will be used for postural stability, static and dynamic balance measurements.

  • Diagnostic testPlantar Pressure Assessment

    When assessing plantar pressure, postural control will be evaluated statically or dynamically, through examination of the behavior of the center of plantar pressure (COP).

06

What researchers measure

Primary outcomes

  1. Navicular Drop Test

    One of the methods used in our study to determine the presence and degree of pes planus is the navicular drop test. If the navicular height difference is between 6-9 mm, it is considered normal MLA, and if it is 10 mm or more, it is considered pes planus.

    Time frame: The evaluation will be conducted once and will be completed within 12 months.

  2. Foot Function Index

    The Foot Function Index consists of 3 subscales: pain, disability and activity limitation. The pain subscale, consisting of nine items, measures the level of foot pain in various situations, while the disability subscale determines the degree of difficulty in performing various functional activities due to foot problems. The five-item activity limitation subscale assesses limitations in activities due to foot problems. Individuals score all items using the Visual Analog Scale (VAS), taking into account their foot condition one week ago. To calculate subscale and total scores, the score for each item is summed, divided by the sum of the maximum scores of the items and multiplied by 100. Higher scores indicate more pain, disability and activity limitation.

    Time frame: The evaluation will be conducted once and will be completed within 12 months.

  3. UFAA-International Physical Activity Questionnaire

    In our study, the self-administered short form of the questionnaire, which includes the "last seven days", will be used to assess physical activity level. Minutes, days and METs (multiples of resting oxygen consumption) are multiplied to obtain a score as "MET-minutes/week". Physical activity levels are classified as physically inactive (\<600 MET-min/week), low physical activity (600 - 3000 MET-min/week) and adequate physical activity (\>3000 MET-min/week). In the calculation of energy expenditure for physical activities, the weekly duration (minutes) of each activity is multiplied by the MET energy values created for the International Physical Activity Questionnaire. Thus, energy expenditures for vigorous, moderate, walking, sitting and total physical activities for each individual are obtained in MET-min/week.

    Time frame: TThe evaluation will be conducted once and will be completed within 12 months.

  4. Evaluation of Diaphragmatic Functions

    The evaluations will be performed with B-mode for bilateral hemidiaphragm in the supine position of the participant. Thickness measurements will be made between hyperechoic peritoneal and pleural borders and recorded in mm (24,25). The thickening fraction (%), which shows the constrictibility of the muscle, in other words, the change in thickness, will be calculated using the formula "(deep inspiration thickness-calm expiration thickness) x 100 / calm expiration thickness

    Time frame: The evaluation will be conducted once and will be completed within 12 months.

  5. Evaluation Balance

    NeuroCom Balance Master balance and performance test device (NeuroCom System Version 8.1.0, B 100718, 1989- 2004 NeuroCom® International Inc. USA) will be used for the evaluation of balance. Balance master is a valid and reliable test device widely used in postural stability, static and dynamic balance measurements.

    Time frame: The evaluation will be conducted once and will be completed within 12 months.

  6. Plantar Pressure Assessment

    Tekscan MatScan™ Pressure Mat System (Tekscan Inc. Boston, USA) will be used to evaluate plantar pressure in the study.The assessments will be performed statically and dynamically. COF ellipse area (cm2), COF velocity (cm/s), COF deviation length (cm), anteroposterior deviation COFx (cm), mediolateral deviation COFy (cm) data obtained in the evaluations and weight values for right-left and anteroposterior feet will be recorded.

    Time frame: The evaluation will be conducted once and will be completed within 12 months.

07

Study locations

1 of 1 sites recruiting
  • Alanyaaku
    Antalya, Alanya, Turkey
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06491212
Lead sponsor
Alanya Alaaddin Keykubat University
Responsible party
Ayça Araci (Assistant professor, Alanya Alaaddin Keykubat University) — Principal investigator
First posted
Jul 9, 2024
Start date
May 1, 2024
Primary completion
Sep 1, 2024 (estimated)
Completion
Oct 15, 2024 (estimated)
Last update
Jul 9, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion